KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Receivables: 2010-2021

Historic Change in Receivables for TherapeuticsMD (TXMD) over the last 12 years, with Dec 2021 value amounting to $4.3 million.

  • TherapeuticsMD's Change in Receivables fell 439.82% to -$13.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$4.3 million, marking a year-over-year decrease of 130.19%. This contributed to the annual value of $4.3 million for FY2021, which is 47.39% down from last year.
  • As of FY2021, TherapeuticsMD's Change in Receivables stood at $4.3 million, which was down 47.39% from $8.2 million recorded in FY2020.
  • TherapeuticsMD's Change in Receivables' 5-year high stood at $13.7 million during FY2019, with a 5-year trough of -$167,691 in FY2017.
  • Over the past 3 years, TherapeuticsMD's median Change in Receivables value was $8.2 million (recorded in 2020), while the average stood at $8.7 million.
  • In the last 5 years, TherapeuticsMD's Change in Receivables slumped by 104.22% in 2017 and then surged by 4,245.15% in 2018.
  • Over the past 5 years, TherapeuticsMD's Change in Receivables (Yearly) stood at -$167,691 in 2017, then surged by 4,245.15% to $7.0 million in 2018, then skyrocketed by 96.39% to $13.7 million in 2019, then slumped by 39.76% to $8.2 million in 2020, then plummeted by 47.39% to $4.3 million in 2021.